Nature Cancer

OCT 29, 2026 · JOURNAL ARTICLE

A genome‑wide screen in E. coli reveals metabolic adaptations that enhance intratumoral fitness and bacterial cancer therapy efficacy

Nature Cancer

Abstract Despite decades of investigation, the fundamental molecular and cellular principles that enable bacteria to thrive within the tumor microenvironment have yet to be defined

SEP 14, 2026 · JOURNAL ARTICLE

Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial

Nature Cancer

Oxaliplatin–fluoropyrimidine combinations are standard adjuvant therapy after radical resection of high-risk stage II and stage III colon cancer but expose many patients to toxicit

SEP 9, 2026 · JOURNAL ARTICLE

Commensal Nakaseomyces glabratus migrates into prostate tumors to accelerate cancer progression

Nature Cancer

Mechanistic discovery in animal models with correlative human data; no clinical trial evidence, no intervention tested in patients, and no hard clinical outcomes reported.